ground hope product
follow earn lower ep estim top-lin rais
price target appear turn corner oper execut
emerg quickli current downturn
conundrum mmm short cycl busi model histori suggest
emerg downturn rapidli howev outlook littl
cloudi first year post downturn normal compani
boost sale respir sale may revers
care earn outlook remain question mark
come target sale guid sever year despit healthi
market backdrop peer perform margin may cap re-invest
need asid short-term bounc acelity-rel cost abat
margin turn corner struggl high decrement margin
mute sale declin last month gross margin bare expand
sale grow howev encourag
sign clean firm-wid gross margin expand y-o-i
segment show impress oper margin expans profit
benefit mi compani lower input cost oil healthi
price power tailwind like cost variabl
temporari clear help margin recoveri watch
close see start exhibit better product on-going basi
histor context sixth mmm downturn
new downturn depend one treat flat sale perform
purist us optimist curiou whether mmm product effort may
bear fruit recent past prefer latter approach show
insid look cheap rel basi vs compar stage prior
downturn regardless whether classifi downturn first sixth
quarterli annual ep usd
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
idc link barclay live interact chart
underweight benefit
recoveri china auto electron
think oper leverag recoveri
like mute given uneven record cost
control recent year balanc sheet usag like
constrain rise pfa afff litig risk
improv price perform industri
leverag return growth auto electron
continu short cycl weak larger expect
margin return data
balanc sheet cash flow mn
equival
short long-term debt
flow oper
valuat leverag metric
show ep bridg
ep bridgestart ep volum price core declinesraw revers charg increment savingsproduct bt footprint relat acel march issuanceoth expens exc-interest flat y-o-ypens rate one time offic sale gaintax tax rate assumedshar share repurchas assumedend ep ep ep bridgestart ep volum price core growthraw restructur savingsproduct bt footprint expect tax rateshar assum buy-back ep ep barclay compani
assum organ sale declin trough return flat
safeti industri return growth first buoy demand mask respir
show organ sale growth forecast near-term
organ sale segment
adj ebit decrement margin guid look reason estim
note much cost save plan announc today tie
discretionari spend travel expens would expect save
y-o-i relief margin organ drop-through fy primari driver
margin improv absenc cost also help
show overal y-o-i adjust margin bridg
margin organ price/raw strateg invest inc-growth transact margin end equiv def oper margin yoy chang chang margin barclay compani
one reason remain uw even though sale recoveri look like
next month last saw sale recoveri
downturn oper leverag fairli low particularli compar short cycl
industri peer give credit adj oper profit growth fy
mmm oper leverag fairli low last short cycl recoveri
inventori
histor run balanc sheet leverag well mi peer higher
buyback recent year coupl acel deal mean leverag
slightli mi averag
assum buy-back spend post remain level
step significantli buy-back freez current in-plac
look forward hear detail pfa litig issu
book paid worth charg signific litigation-rel
background topic pleas see report pfas/pfos/pfoa liabil
june us multi-industri pfa afff updat ahead
might event utx decemb
show framework assess potenti pfa afff liabil
remind emb liabil price
manufactur site surround landfil impact state manufactur site impact individualsmid-downstream co liabil share condens use case militari basescondens use case broader populationexposur mn charg natur resourc damag charg relat manufactur charg relat manufacturingdupont chemour settlement individu peopl per person total popul affect area book charg relat custom militari site contamin drink drink site us serv popul contamin includ militari addit site manufactur pfa chemic total manufactur site surround area landfil etc case assum risk payment mid-downstream compani cite pfas/afff court casespentagon found pfo militari base estim cleanup known contamin site could accord pentagonassum dupont pay-out per settlement concentr contamin product level wit mnput class action ag per co liabil partassum similar portion settlement per affect popul dupont addit site charg per site assum charg similar magnitud mn pentagon per person popul affect area portion affect popul receiv settlement less militari base spendpotenti liabil probabl rationalepreced probabl prove causationpreced like absorb high portion liabilitylow probabl prove causationprob weight potenti liabil total probabl weight potenti pfa charg charg charg charg charg barclay compani
end downturn assum new one begin in-
line april sale trend mmm valuat rel price-to-earnings basi look cheap
rel basi least compar point prior downturn
price perf rel vs prior short cycl downturn
price-to-earnings rel vs prior short cycl downturn
expect return growth
price perf rel vs prior short cycl upturn
price-to-earnings rel vs prior short cycl upturn
barclay research estim compani data unit per share unless otherwis specifi
barclay research estim compani data unit
incom expens tax tax dilut chang current total current total current portion long-term trade current current lt lt total sharehold total liabil sharehold barclay compani
barclay research estim compani data unit
barclay research estim compani data unit
incom inc chang work flow cash flow flow flow total cash transport corpor total yoy revenu changesafeti transport segment corpor oper ebit marginsafeti barclay compani
new underweight rate target price predic upon follow
ebitda price-to-earnings ep yield also capit valu
relat pfa risk
old underweight rate target price predic upon follow
ebitda price-to-earnings ep yield also capit valu
relat pfa risk
barclay research compani data unit multipl per share unless otherwis specifi
 industrialtransport electronicshealth consumerseg totalsal oper end-market split abras adhes tape auto closur mask electr market person safeti roof granul materi auto aero solut electron transport safeti solut oral health sy food safeti separ purif stationeri offic improv consum health soldperson safeti adhes tape abras closur mask system electr market automot aftermarket roof granul segmentalso includ unic market divis substanti sold refriger filtrat product line within safetyand industri electron display materi system electron materi solut automot aerospac commercialsolut advanc materi transport safeti skin wound care infect prevent patient warm solut oral care solut code reimburs softwar food safeti indic solutionsconsum tape reposition note air filtrat clean product home consum bandag brace support retail abras divis headmichael valeashish khandpurmojdeh poul paul keelmajor brandsindustri scotch-weld meguiar bondo vhb cubitron ii filtret safeti scotchprint thinsul speedgla peltor diamond grade scotch-brit envis graphicsviku scotch super tartannexcar littmann clintrac tegadermscotch tape scotch-brit scotch gard post-it andcompetitorsindustri henkel illinoi tool work pentair safeti honeywel illinoi tool work amphenol corningsteri johnson johnson procter gambl church dwight newel rubbermaiddistributionindustri distributiongeograph sale split unit companysegmentsafeti splitsafeti splitunit destinationnon-residenti build build compon aero inc inc move consum cycl industri market split barclay compani
julian mitchel herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
